Dry eye in childhood: Epidemiological and clinical aspects

Ocular Surface

Volumn 6, Issue 1, 2008, Pages 44-51

  Alves, Monica ^a   Dias, Ana Carolina ^b   Rocha, Eduardo Melani ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmune disease; Congenital disorders; Dry eye; Endocrine disorders; Genetic disease; Inflammatology disease; Pediatric dry eye; Tear film; Vitamin A

Indexed keywords

ANTIINFLAMMATORY AGENT; ARTIFICIAL TEAR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN A; DOXYCYCLINE; ERYTHROMYCIN; EYE DROPS; IMMUNOSUPPRESSIVE AGENT; RETINOID DERIVATIVE; STEROID; TETRACYCLINE; VALPROIC ACID;

ALLGROVE SYNDROME; AUTOIMMUNE DISEASE; AWARENESS; BONE DEVELOPMENT; CHILD; CHILDHOOD DISEASE; CONGENITAL DISORDER; CORNEA DISEASE; CROHN DISEASE; CYSTIC FIBROSIS; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRY EYE; DYSAUTONOMIA; EARLY DIAGNOSIS; ECTODERMAL DYSPLASIA; ENVIRONMENTAL FACTOR; ERYTHEMA MULTIFORME; EYE ALLERGY; EYELID DISEASE; GLAUCOMA; GRAFT VERSUS HOST REACTION; HORMONAL THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; INTERDISCIPLINARY COMMUNICATION; JUVENILE RHEUMATOID ARTHRITIS; LACRIMAL APPARATUS; METABOLIC REGULATION; PATHOGENESIS; REVIEW; SCAR FORMATION; SCHIRMER TEST; SIDE EFFECT; SJOEGREN SYNDROME; SLIT LAMP; STEVENS JOHNSON SYNDROME; SUBCAPSULAR CATARACT; SURGICAL TECHNIQUE; TOOTH DEVELOPMENT; TOXIC EPIDERMAL NECROLYSIS; ULCER; VISUAL ACUITY; DISEASE PREDISPOSITION; HEALTH; MORBIDITY; PROGNOSIS; RISK FACTOR; VISUAL SYSTEM EXAMINATION;

CHILD; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DISEASE SUSCEPTIBILITY; DRY EYE SYNDROMES; HUMANS; MORBIDITY; PROGNOSIS; RISK FACTORS; WORLD HEALTH;

EID: 44249115632     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70104-0     Document Type: Article

References (85)

1. Apt L, Cullen BF. Newborns do secrete tears. JAMA 1964;189:951-3
2. [No allLhors listed]. The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:93-107
3. [No authors listed]. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75-92
4. Dogru M, Karakaya H, Baykara M, et al. Tear function and ocular surface findings in premature and term babies. Ophthalmology 2004; 111:901-5
5. Isenberg SJ, Apt L, McCarty J, et al. Development of tearing in preterm and term neonates. Arch Ophthalmol 1998;116:773-6
6. Gold-von Simson G, Axelrod FB. Familial dysautonomia: up-date and recent advances. Curr Probl Pediatr Adolesc Health Care 2006;36:218-37
7. Axelrod FB. Familial dysautonomia. Muscle Nerve 2004;29:352-63
8. Francois J. The Riley-Day syndrome. Familial dysautonomy, central autonomic dysfunction. Ophthalmologica 1977;174:20-34
9. Karpik AG, Streeten BW, Spitzer KH, McGraw JL. Corneal transplantation in familial dysautonomia. Am J Ophthalmol 1979,88:993-9
10. Mondino BJ, Brown SI. Hereditary congenital alacrima. Arch Ophthalmol 1976;94:1478-84
11. Houlden H, Smith S, De Carvalho M, et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 2002;125(Pt 12):2681-90
12. Chiheb S, Slaoui Z, Nejjam F, et al. [Allgrove's syndrome]. Ann Dermatol Venereol 2001;128(10 Pt 1):1043-5
13. Chu ML. Berlin D, Axelrod FB. Allgrove syndrome: documenting cholinergic dysfunction by autonomic tests. J Pediatr 1996-129:156-9
14. Makari G, Hoffman WH, Carroll JE, et al. Autonomic dysfunction and adrenocortical unresponsiveness to ACTH. J Child Neurol 1988;3:174-6
15. Brooks BP, Kleta R, Caruso RC, et al. Triple-A syndrome with prominent ophthalmic features and a novel mutation in the AAAS gene: a case report. BMC Ophthalmol 2004;4:7
16. Davidoff E, Friedman AH. Congenital alacrima. Surv Ophthalmol 1977;22(2):113-9
17. Yoshi La T, Kobayashi A, Sugiyama K. Bilateral corneal perforation in an infant with congenital alacrima. J Pediatr Ophthalmol Strabismus 2006;43:236-8
18. Arya SK, Chaudhuri Z, Jain R, et al. Congenital alacrima in Pierre Robin sequence. Cornea 2004;23:632-4
19. Kaercher T. Ocular symptoms and signs in patients with ectodermal dysplasia syndromes. Graefes Arch Clin Exp Ophthalmol 2004;242:495-500
20. Messmer EM, Kenyon KR, Rittinger O, et al. Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome. Ophthalmology 2005;112:e1-6
21. Bonnar E, Logan P, Eustace P. Absent meibomian glands: a marker for EEC syndrome. Eye 1996; 10 (Pt 3):355-61
22. Mohammad M, Javadi MA. Keratitis associated with multiple endocrine deficiency. Cornea 2006;25:112-4
23. Mrugacz M, Zak J, Bakunowicz-Lazarczyk A, et al. Flow cytometric analysis of HLA-DR antigen in conjunctival epithelial cells of patient with cystic fibrosis. Eye 2007;21:1062-6
24. Mrugacz M, Kasacka I, Bakunowicz-Lazarczyk A, et al. Impression cytology of the conjunctival epithelial cells in patients with cystic fibrosis. Eye 2007; May 25 (Epub ahead of print.)
25. Mrugacz M, Zelazowska B, Bakunowicz-Lazarczyk A, et al. Elevated tear fluid levels of MIP-1alpha in patients with cystic fibrosis. J Interferon Cytokine Res 2007;27:491-5.
26. Morkeberg JC, Edmund C, Prause JU, et al. Ocular findings in cystic fibrosis patients receiving vitamin A supplementation. Graefes Arch Clin Exper Ophthalmol 1995;233:709-13.
27. Thouret MC, Sirvent N, Triolo V, et al. Primary Gougerot-Sjogren syndrome in a 13-year-old girl. Arch Pediatr 2002;9:142-6
28. Stiller M, Golder W, Doring E, Biedermann T. Primary and secondary Sjogren's syndrome in children - a comparative study. Clin Oral Investig 2000;4:176-82
29. Anaya JM, Ogawa N, Talal N. Sjogren's syndrome in childhood. J Rheumatol 1995;22:1152-8
30. Cimaz R, Casadei A, Rose C, et al. Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 2003;162:661-5
31. Ostuni PA, Ianniello A, Sfriso P, et al. Juvenile onset of primary Sjogren's syndrome: report of 10 cases. Clin Exp Rheumatol 1996;14:689-93
32. Manthorpe R, Svensson A, Wirestrand LE. Late neonatal lupus erythematosus onset in a child born of a mother with primary Sjogren's syndrome. Ann Rheum Dis 2004;63:1496-7
33. Lee LA. Neonatal lupus erythematosus. J Invest Dermatol 1993;100:9S-13S
34. Sub DW, Ruttum MS, Stuckenschneider BJ, et al. Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 1999;106:1564-70
35. Ng JS, Lam DS, Li CK, et al. Ocular complications of pediatric bone marrow transplantation. Ophthalmology 1999;106:160-4
36. Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant 2006;38:223-7
37. Bonini S, Lambiase A, Marchi S, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 2000;107:1157-63
38. Dogru M, Okada N, Asano-Kato N, et al. Atopic ocular surface disease: implications on tear function and ocular surface mucins. Cornea 2005;24(8 Suppl):S18-S23
39. Hu Y, Matsumoto Y, Dogru M, et al. The differences of tear function and ocular surfsce findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy 2007:62:917-25
40. Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol 1999;34:88-92
41. Fujishima H, Toda I, Shimazaki J, Tsubota K. Allergic conjunctivitis and dry eye. Br J Ophthalmol 1996;80:994-7
42. Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology 1995;102:302-9
43. Onguchi T, Dogru M, Okada N, et al. The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings. Am J Ophthalmol 2006;141:569-71
44. Paula J, Bonini-Filho MA, Schirmbeck T, et al. Comparative study of diagnostic tools for dry eye among normal and juvenile reumathoid arthritis children. Arq Bras Oftalmol 2004;67:769-72
45. Akinci A, Cakar N, Uncu N, et al. Keratoconjunctivitis sicca in juvenile rheumatoid arthritis. Cornea 2007;26:941-4
46. Mrugacz M, Sredzinska-Kita D, Cyrta-Jarocka E, Bakunowicz-Lazarczyk A. Dry eye syndrome and cataract as ocular manifestations of Crohn's disease. Klin Oczna 2005;107:509-10
47. Wolkoff P, Nojgaard JK, Troiano P, Piccoli B. Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med 2005;62:4-12
48. Sommer A. Xerophthalmia and vitamin A status. Prog Retin Eye Res 1998;17:9-31
49. Velasco Cruz AA, Attie-Castro FA, Fernandes SL, et al. Adult blindness secondary to vitamin A deficiency associated with an eating disorder. Nutrition 2005;21:630-3
50. Ramsay A, Sabrosa NA, Pavesio CE. Bitot's spots and vitamin A deficiency in a child from die UK. Br J Ophthalmol 2001;85:372
51. Rayner RJ, Tyrrel JC, Hiller EJ, et al. Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis. Arch Dis Child 1989;64:1151-6
52. Cella W, Urbano AP, Vinhadelli WS, et al. Xerophthalmia secondary to short bowel syndrome. J Pediatr Ophthalmol Strabismus 2002; 39:125-7
53. Feranchak AP, Gralla J, King R, et al. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology 2005;42:782-92
54. Lebowitz MA, Berson DS. Ocular effects of oral retinoids. J Am Acad Dermatol 1988;19(1 Pt 2):209-11
55. Ramaesh K, Stokes J, Henry E, et al. Congenital corneal anesthesia. Surv Ophthalmol 2007;52:50-60
56. Tan MH, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea 2006;25:352-5
57. Mathen MM, Vishnu S, Prajna NV, et al. Congenital corneal anesthesia: a series of four case reports. Cornea 2001;20:194-6
58. Chang YS, Huang FC, Tseng SH, et al. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 2007;26:123-9
59. Pushker N, Tandon R, Vajpayee RB. Stevens-Johnson syndrome in India - risk factors, ocular manifestations and management. Ophthalmologica 2000;214:285-8
60. Foster CS, Fong LP, Azar D, Kenyon KR. Episodic conjunctival inflammation after Stevens-Johnson syndrome. Ophthalmology 1988;95:453-62
61. Coats DK, Paysse EA, Kim DS. Excessive blinking in childhood: a prospective evaluation of 99 children. Ophthalmology 2001;108:1556-61
62. Lemp MA. Reportof the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32
63. Bron AJ, Benjamin L, Smbson GR. Meibomian gland disease. Classification and grading of lid changes. Eye 1991;5 (Pt 4):395-411
64. Paula JS, Bonini-Filho MA, Schirmbeck T, et al. Comparative study of diagnostic tools for dry eye among normal and juvenile rheumatoid arthritis children. Arq Bras Oftalmol 2004;67:769-72
65. Pflugfelder SC, de Paiva CS, Tong L, et al. Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease. Ocul Surf 2005;3(4 Suppl):S154-7
66. Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006;47:4309-15
67. Mac Cord Medina F, Silvestre de Castro R, Leite SC, et al. Management of dry eye related to systemic diseases in childhood and longterm follow-up. Acta Ophthalmol Scand 2007;85:739-44
68. Hasenbein W, Albani J, Englert C, et al. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Pediatr Transplant 2006;10:938-42
69. Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol 2002;89:298-303
70. Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005:139:242-6
71. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115-20
72. Isenberg SJ, Del Signore M, Chen A, et al. The lipid layer and stability of the preocular tear film in newborns and infants. Ophthalmology 2003;110:1408-11
73. Chan I, Harper JI, Mellerio JE, McGrath JA. ADULT ectodermal dysplasia syndrome resulting from the missense mutation R298Q in the p63 gene. Clin Exp Dermatol 2004;29:669-72
74. Tong L, Hodgkins PR, Denyer J, et al. The eye in epidermolysis bullosa. Br J Ophthalmol 1999;83:323-6
75. Nazir SA, Murphy S, Siatkowski RM, et al. Ocular rosacea in childhood. Am J Ophthalmol 2004;137:138-44
76. Kobayashi A, Yoshita T, Sugiyama K, et al. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement. Ophthalmology 2006;113:126-32
77. Sheridan RL, Schulz JT, Ryan CM, et al. Long-term consequences of toxic epidermal necrolysis in children. Pediatrics 2002;109:74-8
78. Sullivan BD, Evans JE, Cermak JM, et al. Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol 2002;120:1689-99
79. Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol 2000;84:19-21
80. Menon PS, Singh GR. Hyperthyroidism in children: an Indian experience. J Pediatr Endocrinol Metab 1996;9:441-6
81. Tsubota K, Fujishima H, Toda I, et al. increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjogren's syndrome patients. Acta Ophthalmol Scand 1995;73:425-30
82. Keijser S, van Best JA, Van der Lelij A, Jager MJ. Reflex and steady state tears in patients with latent stromal herpetic keratitis. Invest Ophthalmol Vis Sci 2002:43:87-91
83. Chronister CL, Lee A, Kaiser H. Rarely reported cases of congenital atresia of nasolacrimal puncta. Optometry 2002;73:237-42
84. de Jong C, Stolwijk T, Kuppens E, et al. Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol 1994;232:221-4
85. Murube J, Nemeth J, Hoh H, et al. The triple classification of dry eye for practical clinical use. Eur J Ophthalmol 2005;15:660-7